Donald Trump kicked off a new era of Western economic rivalry with Beijing when he took office in 2017. As he prepares for his second term, China’s dominance of global manufacturing is greater ...

Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab ... M.B.B.S., F.R.A.C.P., ...

[cemiplimab] was the first PD-1 inhibitor approved for certain patients with advanced cutaneous squamous cell carcinoma and has become a standard of care in this setting,” said Israel Lowy, MD, PhD, ...

The new group will be led by Jay Parikh, Facebook's former head of engineering whom Nadella added to Microsoft's senior leadership team in October. Microsoft is forming the group as it anticipates ...

Cemiplimab (Libtayo, Regeneron Pharmaceuticals ... FRACP, research lead of head and neck cancer and cutaneous squamous cell carcinoma in the department of medical oncology at Peter MacCallum ...

El Clasico is always a fiery affair. Lionel Messi (centre) and Sergio Ramos (right) go head-to-head. / AFLOSPORT/IMAGO Real Madrid versus Barcelona, best known as El Clásico, is the most famous ...